Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Abiraterone plus prednisone added to androgen deprivation... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
0
Authors
Karim Fizazi
32 more
Karim Fizazi
•
Stéphanie Foulon
30 more
•
Alberto Bossi
Published
April 1, 2022
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Cancer Oncology
Internal Medicine
Hematology
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/s0140-6736(22)00367-1
License
publisher-specific-oa
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet
Topics
Medicine
Cancer Oncology
Internal Medicine
Hematology
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1016/s0140-6736(22)00367-1
License
publisher-specific-oa
